Instalab

Eikenella corrodens Test

Catch a hidden oral bacterium driving gum disease, deep abscesses, or heart valve infections that routine cultures often miss.

Who benefits from Eikenella corrodens testing

Dealing With Stubborn Gum Problems
Find out whether a specific bacterium is driving inflammation that standard cleanings have not resolved.
Living With Dental Implants
Catch peri-implant infection early, before it threatens the bone holding your implant in place.
Living With a Heart Valve Condition or Implant
Track an oral bacterium known to seed heart valve infections, especially relevant before major dental procedures.
Planning or Carrying a Pregnancy
Assess oral pathogens linked to preterm birth and low birth weight, particularly if you have active gum disease.

About Eikenella corrodens

You probably have Eikenella corrodens living in your mouth right now. For most people, that is fine. This slow-growing bacterium is a normal resident of dental plaque, the throat, and the upper airway. The problem starts when it leaves its usual home, either through a bite wound, a dental procedure, a swallowed fish bone, or simply through gum disease that lets oral bugs slip into the bloodstream.

When that happens, E. corrodens can cause deep abscesses, heart valve infections, and chronic gum disease that standard care often misses. It grows slowly, hides in mixed infections, and resists several common antibiotics that doctors reach for first. Knowing whether it shows up in your oral microbiome, blood culture, or wound sample changes what treatment will actually work.

What This Test Detects

E. corrodens (full name Eikenella corrodens) is a small, oxygen-tolerant, Gram-negative rod, meaning it belongs to a family of bacteria whose cell walls stain a specific color under the microscope. It is part of the HACEK group, an acronym for five hard-to-grow mouth bacteria that share a reputation for causing slow, sneaky infections of the heart valves.

The test identifies whether this bacterium is present in a sample, typically saliva, dental plaque, blood, or fluid drawn from an infected site. Detection is done either by growing the bacterium on special culture plates with extra carbon dioxide or by spotting its DNA using molecular methods. Finding it in the mouth is normal. Finding it in the bloodstream, joint fluid, abscess pus, or pericardial fluid (the sac around the heart) signals real infection.

Why It Matters for Gum and Implant Disease

In the mouth, higher amounts of E. corrodens track with gum inflammation, deeper pockets around teeth, and disease around dental implants. A study of 213 implant patients found this bacterium at higher levels at implants with mucositis (inflammation of the gum around an implant) than at healthy implants, with E. corrodens levels also correlating with deeper probing depths around implants, a feature of peri-implantitis (the more severe form involving bone loss).

In younger people, the bug also appears more often in subgingival plaque (the layer of bacteria below the gumline) when periodontitis is present. A study of 273 patients found a higher proportion in young patients with periodontal disease compared to healthy peers, raising the possibility that this organism plays a role in early-onset gum breakdown. A separate study of 166 people showed that obesity is linked to higher proportions of this bacterium in diseased sites.

Adverse Pregnancy Outcomes

Oral bacteria do not always stay in the mouth. In a study of 57 placentas, oral bacteria including E. corrodens were detected at higher rates in placentas from pregnant women with periodontitis than from women without gum disease. A Spanish study of 177 women linked the presence of specific oral pathogens in subgingival plaque to preterm birth and low birth weight. The mouth-pregnancy connection is not fully resolved, but the data make a case for taking gum health seriously when planning or carrying a pregnancy.

Heart Valve Infection (HACEK Endocarditis)

E. corrodens is one of the HACEK organisms, a small group of mouth bacteria responsible for a slow-burning form of infective endocarditis (infection of the heart valves). In a multinational cohort of 5,591 cases of infective endocarditis, HACEK endocarditis tended to affect younger patients, came with more immunologic and vascular complications, and was more likely to involve stroke, yet had better in-hospital survival than infections from other organisms when treated promptly.

A population-based study of 118 HACEK bacteremia cases reported that progression to endocarditis was common in higher-risk subgroups, especially in people with cardiac implants, predisposing valve conditions, long symptom duration, or multiple positive blood cultures. If E. corrodens turns up in a blood culture without an obvious source, the working assumption should be endocarditis until imaging proves otherwise.

Coronary Artery Disease

An oral microbiome study of 30 Tunisian adults reported that the abundance of Eikenella in mouth samples correlated with coronary artery disease severity, raising the possibility that this organism could serve as part of an oral microbiome signature linked to heart disease risk. This is early research, not a clinical test, but it adds to the broader story connecting oral bacteria to vascular outcomes.

Deep Tissue Infections

When E. corrodens escapes its normal habitat, it can seed serious infections almost anywhere. A series of 43 invasive cases showed polymicrobial infection (multiple bacteria present at the same time) in 65% of patients, most often alongside streptococci. Reported sites include head and neck abscesses, lung abscess and empyema (pus in the chest cavity), liver and abdominal abscesses, septic arthritis, osteomyelitis (bone infection), orbital cellulitis (infection around the eye), and purulent pericarditis. Mortality in early case series reached 30%, and inadequate empiric antibiotic choices have been linked directly to worse outcomes.

The Antibiotic Trap

This is where E. corrodens trips up clinicians. The bug is usually sensitive to penicillin, ampicillin, third-generation cephalosporins, carbapenems, and some fluoroquinolones. It is reliably resistant to clindamycin and metronidazole, two antibiotics commonly chosen empirically to cover "mouth bugs." If you have a deep oral or dental infection and your prescriber reaches for clindamycin or metronidazole alone, an E. corrodens infection will keep growing. A growing number of strains now also produce beta-lactamase (an enzyme that destroys penicillin-type antibiotics), and a 2026 case report described a multidrug-resistant strain causing maxillary bone infection.

What this means for you: if you have a persistent dental, sinus, or throat infection that is not responding to an antibiotic from the clindamycin or metronidazole family, ask for a culture. Identification of E. corrodens, with susceptibility testing, often changes the prescription and the outcome.

Reference Ranges and What the Result Means

E. corrodens is a Tier 3 marker. There are no standardized quantitative cutpoints from major guideline bodies, and how results are reported varies by lab and specimen type. Salivary and subgingival panels typically give a count, a percentage of total bacteria, or a present/absent flag. Blood cultures and tissue cultures report it as a pathogen identified or not.

The values below come from research studies measuring this organism in different specimen types. They are illustrative orientation rather than universal targets, and your lab will likely report different numbers in different units. Compare your results within the same lab over time for the most meaningful trend.

Specimen and ContextWhat the Result SuggestsSource
Saliva or dental plaque, presentNormal finding in most healthy mouths; does not by itself indicate diseaseChen et al. 1989
Subgingival plaque, elevated proportionAssociated with active gum inflammation, peri-implant disease, or early-onset periodontitisSuda et al. 2002; Renvert et al. 2007
Blood culture, positiveTreated as true infection; strongly suggests endocarditis if no other source identifiedBerge et al. 2020; Sharara et al. 2016
Abscess, joint, pericardial, or tissue culture, positivePathogen confirmed; antibiotic susceptibility testing required to guide therapySheng et al. 2001; Li et al. 2022

Why a Single Reading Can Fool You

E. corrodens grows slowly and has high nutritional requirements, which means it can be missed on routine cultures if the lab is not specifically looking for it. A culture that comes back "no growth" does not always mean the organism is absent. Three specific pitfalls are worth knowing:

  • Slow growth: the bacterium can take several days to appear on culture plates. Labs that finalize cultures too quickly may report a false negative.
  • Polymicrobial infections: when faster-growing bacteria are present, E. corrodens can be overlooked. A 43-patient series found 65% of invasive infections were polymicrobial.
  • Recent antibiotics: if you took penicillin, amoxicillin, or a cephalosporin before the sample was collected, the culture may not grow the organism even when it is still driving inflammation.

Tracking Your Trend

For oral health applications, a single salivary or subgingival reading captures one snapshot of a constantly shifting biofilm. Diet, oral hygiene, recent dental cleanings, and antibiotics all shift the picture. Serial tracking matters more than any single number. If you are using this test to monitor gum disease, peri-implant health, or response to periodontal treatment, a reasonable cadence is a baseline test, a follow-up at 3 months after starting changes to your dental routine, and at least annually thereafter.

For systemic infection workup, the test is binary. Either it grew, or it did not. Repeat blood cultures may be needed to confirm or rule out endocarditis when initial cultures are negative but suspicion remains high.

What an Abnormal Result Should Make You Do

If E. corrodens shows up in a saliva or plaque panel at elevated levels, the next step is a periodontal evaluation. A periodontist can measure pocket depths, check for bleeding on probing, and decide whether scaling and root planing or more advanced therapy is warranted. A randomized trial in 70 periodontitis patients showed that scaling and root planing, with or without targeted antibiotic microspheres, reduced periodontal pathogens and improved clinical outcomes.

If the bacterium shows up in a blood culture, that is a medical emergency until proven otherwise. The pathway is an echocardiogram (an ultrasound of the heart, often a transesophageal one for higher sensitivity), repeat blood cultures, and involvement of an infectious disease physician and often a cardiologist. Treatment requires a beta-lactam antibiotic for several weeks, sometimes combined with surgical valve repair.

If it shows up from an abscess or deep tissue sample, the rule is simple. Drain the abscess and use antibiotics chosen by susceptibility testing, not by oral-flora rules of thumb. Across diverse case series, the combination of surgical drainage plus targeted antibiotics is what cures these infections.

What Moves This Biomarker

Evidence-backed interventions that affect your Eikenella corrodens level

Decrease
Penicillin, amoxicillin, third-generation cephalosporins, or carbapenems for invasive infection
These antibiotic classes are the backbone of treatment when E. corrodens is causing deep infection. In a 43-patient series of invasive infections, isolates were consistently susceptible to penicillin, ampicillin, third-generation cephalosporins, and carbapenems. Choosing the right antibiotic is what determines whether the infection clears. Inadequate empiric therapy has been directly linked to complications and treatment failure.
MedicationStrong Evidence
Increase
Clindamycin or metronidazole as the only antibiotic for an oral or dental infection
Both drugs are commonly prescribed for mouth infections but E. corrodens is reliably resistant to them. Using either as sole therapy allows the bacterium to keep growing while it appears the infection is being treated. Multiple case series describe treatment failures and complications when these drugs were used empirically without coverage for E. corrodens.
MedicationStrong Evidence
Decrease
Scaling and root planing with minocycline microspheres for periodontitis
This is the standard professional treatment for gum disease and it reduces the bacterial load driving inflammation, including E. corrodens and related pathogens. In a randomized trial of 70 people with Stage II to IV Grade B periodontitis, the combined treatment significantly reduced periodontal pathogens including E. corrodens and improved clinical measures of gum health compared to scaling alone.
MedicationModerate Evidence
Increase
Heavy alcohol consumption with existing periodontitis
In a study of 88 adults, those with alcohol dependence and periodontitis had higher levels of periodontal pathogens including E. corrodens in their saliva, along with higher inflammatory markers. The combination of alcohol and existing gum disease appears to worsen the oral bacterial environment.
LifestyleModerate Evidence
Increase
Carrying excess body weight with periodontitis
A study of 166 people found that obese adults with chronic periodontitis had higher proportions of periodontal pathogens including E. corrodens in diseased gum sites compared to lean adults with the same disease severity. The mechanism likely involves systemic inflammation altering the oral microbial environment.
LifestyleModerate Evidence
Increase
Cancer immunotherapy with checkpoint inhibitors like nivolumab
In immunocompromised patients, including those receiving cancer immunotherapy, E. corrodens can move from its usual oral home into the bloodstream or central nervous system. A 2025 case report described E. corrodens bacteremia following a CNS infection in a patient on nivolumab, and lung abscess cases linked to E. corrodens have clustered in patients with cancer or immune suppression. This does not mean these medications cause infection in everyone, but the risk of invasive E. corrodens disease rises when immune defenses are weakened.
MedicationModest Evidence

Frequently Asked Questions

References

23 studies
  1. Li Li, Yubo Shi, X. WengJournal of Clinical Laboratory Analysis2022
  2. C-K Casey Chen, M. WilsonJournal of Periodontology1992
  3. W. Sheng, P. Hsueh, C. Hung, L. Teng, Y.-C. Chen, K. LuhEuropean Journal of Clinical Microbiology and Infectious Diseases2001
  4. C-K Casey Chen, R. Dunford, H. Reynolds, J. ZambonJournal of Periodontology1989